Monday, 2 February 2015

BlueBird's rare blood disorder drug gets breakthrough therapy status

(Reuters) - The U.S. Food and Drug Administration has designated BlueBird Bio Inc's blood disorder drug a breakthrough therapy, speeding up the treatment's development process.


via Reuters: Health News Read More Here..

No comments:

Post a Comment